Kairos Pharma, LTD. KAPA
- carotuximab — Prostate Cancer Phase 2
- carotuximab — Non-Small Cell Lung Cancer Phase 1
- ENV 105 — Head and Neck Cancer Preclinical
endoglin (1 companies · 3 programs)
Companies with an active program directed at endoglin.
Companies with an active program directed at endoglin.